Kryštof Vladimír

Groups: AFFILIATED STAFF, FACULTY OF SCIENCE

LOFFELMANN, M., Z. ŠKROTT, D. MAJERA, P. STARHA, V. KRYŠTOF, M. MISTRÍK

Identification of novel dithiocarbamate-copper complexes targeting p97/NPL4 pathway in cancer cells. European Journal of Medicinal Chemistry. 2023, 261, 115790, ISSN: 0223-5234 , PMID: 37690264,

SHALDAM, M., D. HENDRYCHOVA, R. EL-HAGGAR, V. VOJÁČKOVÁ, T. MAJRASHI, E. ELKAEED, N. MASURIER, V. KRYŠTOF, H. TAWFIK, W. ELDEHNA

2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling. European Journal of Medicinal Chemistry. 2023, 258, 115610, ISSN: 0223-5234, PMID: 37437350,

KOVALOVA, M., J. BARAKA, V. MIK, R. JORDA, M. LUO, H. SHAO, V. KRYŠTOF

A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022). Expert Opinion on Therapeutic Patents. 2023, 33(2), 67-87, ISSN: 1354-3776, PMID: 36975020,

Trofimenková Dominika

Cytoprotective effects of novel selenium-based compounds

Status: Ongoing from 2023.

Kryštof Vladimír

Journals

Doctoral mentorship

Trofimenková Dominika